tradingkey.logo

LeMaitre Vascular Inc

LMAT
查看详细走势图
84.510USD
-0.450-0.53%
收盘 12/22, 16:00美东报价延迟15分钟
1.92B总市值
35.80市盈率 TTM

LeMaitre Vascular Inc

84.510
-0.450-0.53%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-0.53%

5天

+2.10%

1月

-3.89%

6月

+3.34%

今年开始到现在

-8.28%

1年

-8.26%

查看详细走势图

TradingKey LeMaitre Vascular Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

LeMaitre Vascular Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名35/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价104.33。中期看,股价处于平稳状态。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

LeMaitre Vascular Inc评分

相关信息

行业排名
35 / 208
全市场排名
110 / 4582
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 11 位分析师
买入
评级
104.333
目标均价
+25.81%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

LeMaitre Vascular Inc亮点

亮点风险
LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
业绩高增长
公司营业收入稳步增长,连续3年增长36.01%
利润高增长
公司净利润处于行业前列,最新年度总收入219.86M美元
高分红
公司属于高分红公司,最新股息支付率32.65%
稳定分红
公司5年内连续分红,最新股息支付率32.65%
估值低估
公司最新PE估值35.99,处于3年历史低位
机构减仓
最新机构持股21.34M股,环比减少5.36%
詹姆斯·西蒙斯持仓
明星投资者詹姆斯·西蒙斯持仓,最新持仓市值180.60K
活跃度增加
近期活跃度增加,过去20天平均换手率0.42

LeMaitre Vascular Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

LeMaitre Vascular Inc简介

LeMaitre Vascular, Inc. is a provider of devices, implants, and services for the treatment of peripheral vascular disease. The Company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and other specialties, such as cardiac surgeons, general surgeons, and neurosurgeons. Its portfolio of product lines is used to treat vascular disease, which used in open vascular surgery and dialysis access. It also offers human vascular and cardiac tissue cryopreservation services. Its principal product lines include anastomotic clips, biologic vascular and dialysis grafts, biologic vascular and cardiac patches, carotid shunts, embolectomy and occlusion catheters, radiopaque marking tape, synthetic vascular and dialysis grafts, and valvulotomes. Its principal biologic offerings include vascular and cardiac patches as well as vascular and dialysis grafts. Its product offerings are sold primarily in the United States, Europe, Canada, and Asia Pacific.
公司代码LMAT
公司LeMaitre Vascular Inc
CEOLemaitre (George W)
网址https://www.lemaitre.com/

常见问题

LeMaitre Vascular Inc(LMAT)的当前股价是多少?

LeMaitre Vascular Inc(LMAT)的当前股价是 84.510。

LeMaitre Vascular Inc的股票代码是什么?

LeMaitre Vascular Inc的股票代码是LMAT。

LeMaitre Vascular Inc股票的52周最高点是多少?

LeMaitre Vascular Inc股票的52周最高点是105.550。

LeMaitre Vascular Inc股票的52周最低点是多少?

LeMaitre Vascular Inc股票的52周最低点是71.420。

LeMaitre Vascular Inc的市值是多少?

LeMaitre Vascular Inc的市值是1.92B。

LeMaitre Vascular Inc的净利润是多少?

LeMaitre Vascular Inc的净利润为44.04M。

现在LeMaitre Vascular Inc(LMAT)的股票是买入、持有还是卖出?

根据分析师评级,LeMaitre Vascular Inc(LMAT)的总体评级为买入,目标价格为104.333。

LeMaitre Vascular Inc(LMAT)股票的每股收益(EPS TTM)是多少

LeMaitre Vascular Inc(LMAT)股票的每股收益(EPS TTM)是2.361。
KeyAI